Table 6. Systemic and local adverse effects within one week after influenza vaccination in the dialysis patients.
| The first dose at week 0 (n = 170) |
The second dose at 3 weeks later (n = 70) |
|||
|---|---|---|---|---|
| Milda | Moderate to severea | Milda | Moderate to severea | |
| Systemic adverse effect | ||||
| Fever (> 38 °C) | 1.80% | 0.00% | 0.00% | 0.00% |
| Nasal congestion | 4.10% | 1.80% | 2.90% | 0.00% |
| Cough | 6.50% | 1.20% | 5.70% | 0.00% |
| Sore throat | 4.10% | 1.20% | 2.90% | 0.00% |
| Muscle aches | 11.80% | 2.40% | 11.40% | 0.00% |
| Headache | 2.90% | 2.40% | 1.40% | 1.40% |
| Nausea | 1.80% | 1.20% | 1.40% | 1.40% |
| Vomiting | 2.90% | 1.20% | 1.40% | 1.40% |
| Malaise | 17.70% | 1.80% | 12.90% | 0.00% |
| Eye redness | 1.20% | 0.00% | 0.00% | 0.00% |
| Chest tightness | 1.80% | 1.20% | 1.40% | 0.00% |
| Respiratory distress | 1.80% | 1.20% | 1.40% | 0.00% |
| Face edema | 0.00% | 0.00% | 0.00% | 0.00% |
| Local adverse effect | ||||
| Pain | 17.70% | 0.00% | 18.60% | 0.00% |
| Swelling | 2.90% | 0.00% | 2.90% | 0.00% |
| Redness | 0.00% | 0.00% | 0.00% | 0.00% |
| Ecchymosis | 0.60% | 0.00% | 1.40% | 0.00% |
| Decrease limb mobility | 1.20% | 0.00% | 1.40% | 0.00% |
aThe severity of the symptoms were defined as: (a) mild: symptoms are easily tolerable; (b) moderate: symptoms interfere with the daily activity; (c) severe: unable to work or perform daily activity due to symptoms. In the item of “fever”, ≥ 38.0 °C ~ 39.0 °C was defined as mild, >39.0 °C ~ 40.0 °C as moderate and > 40.0 °C as seve